Analyst Upgrades Signal Renewed Growth Cycle for Edwards Lifesciences Corporation (EW) [Yahoo! Finance]
Edwards Lifesciences Corporation (EW)
Last edwards lifesciences corporation earnings: 4/23 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.edwards.com
Company Research
Source: Yahoo! Finance
of Edwards Lifesciences Corporation (NYSE:EW) to $110 from $105 while reiterating a Buy rating. The price target hike is in response to a significant increase in the number of Transcatheter Aortic Valve Replacement (TAVR) procedures. After surveying physicians who perform the procedure, the results indicate significant growth in TAVR. Likewise, the results point to improvement in TAVR market fundamentals. The results align with the company's revenue growing by 10% in the third quarter, driven by growth in the TAVR division, which accounts for 75% of total revenue. It is the strongest growth for the division in recent years. Earlier, on January 9, TD Cowen upgraded Edwards Lifesciences to a Buy from Hold and raised the price target to $97 from $90. The price target hike is in response to the company entering what the research firm touts as a renewed growth cycle, driven by expanded indications for transcatheter aortic valve replacement (TAVR). Edwards Lifesciences Corporation (NY
Show less
Read more
Impact Snapshot
Event Time:
EW
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EW alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EW alerts
High impacting Edwards Lifesciences Corporation news events
Weekly update
A roundup of the hottest topics
EW
News
- Edwards Lifesciences Refocuses On Core TAVR And Mitral Growth Story [Yahoo! Finance]Yahoo! Finance
- Should Weakness in Edwards Lifesciences Corporation's (NYSE:EW) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? [Yahoo! Finance]Yahoo! Finance
- Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care ConferenceBusiness Wire
- Edwards Lifesciences (NYSE:EW) was given a new $110.00 price target on by analysts at Stifel Nicolaus.MarketBeat
- Edwards Lifesciences (NYSE:EW) had its "overweight" rating reaffirmed by analysts at Piper Sandler.MarketBeat
EW
Earnings
- 10/30/25 - Beat
EW
Sec Filings
- 1/12/26 - Form 8-K
- 1/9/26 - Form 4
- 1/6/26 - Form 4
- EW's page on the SEC website